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Abstract
Background: Extensive biomedical studies have shown that clinical and environmental risk factors may not have
sufficient predictive power for cancer prognosis. The development of high-throughput profiling technologies
makes it possible to survey the whole genome and search for genomic markers with predictive power. Many
existing studies assume the interchangeability of gene effects and ignore the coordination among them.
Results: We adopt the weighted co-expression network to describe the interplay among genes. Although there
are several different ways of defining gene networks, the weighted co-expression network may be preferred
because of its computational simplicity, satisfactory empirical performance, and because it does not demand
additional biological experiments. For cancer prognosis studies with gene expression measurements, we propose a
new marker selection method that can properly incorporate the network connectivity of genes. We analyze six
prognosis studies on breast cancer and lymphoma. We find that the proposed approach can identify genes that
are significantly different from those using alternatives. We search published literature and find that genes
identified using the proposed approach are biologically meaningful. In addition, they have better prediction
performance and reproducibility than genes identified using alternatives.
Conclusions: The network contains important information on the functionality of genes. Incorporating the network
structure can improve cancer marker identification.
Background
Cancer is a complex disease. Extensive biomedical stu-
dies have shown that clinical and environmental risk
factors may not have sufficient predictive power for can-
cer prognosis. The development of high-throughput
profiling technologies makes it possible to survey the
whole genome and search for genomic markers that
may have independent predictive power for cancer prog-
nosis [1]. Gene signatures have been constructed for the
prognosis of breast cancer, lymphoma, ovarian cancer,
and many others [2]. In this article, we focus on gene
expression data measured using microarrays but note
that the proposed approach is also applicable to other
profiling techniques.
Denote T as the cancer survival time and C as the
censoring time. Denote X as the length-d gene expres-
sion measurements. Under right censoring, one observes
(Y = min(T, C), Δ = I(T ≤ C), X). In cancer genomic
studies, the sample size n is much smaller than d.
Dimension reduction or feature selection is needed
along with model estimation [3-5]. Dimension reduction
methods construct a small number of “super genes”
using the linear combinations of all genes, whereas fea-
ture selection methods select a subset of important
genes. Literature review suggests that performance of
different methods is data-dependent, with no one domi-
nating the other. The proposed method conducts feature
selection. Since it is not the focus of this article, dimen-
sion reduction methods will not be further discussed.
Many existing methods assume the interchangeability
of genes and ignore the interplay among them. Recent
biomedical studies suggest that there is an inherent
coordination among genes and, essentially, all biological
functions of living cells are carried out through the
coordinated effects of multiple genes. There are many
ways of describing the interplay among genes. In this
article, we focus on the gene network. In network analy-
sis, nodes represent genes. Nodes are connected if the
genes have similar biological functions and/or correlated
expressions. There are subsets of nodes called “modules” * Correspondence: shuangge.ma@yale.edu
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defining the relative importance of a gene within a net-
work is the connectivity, which measures how well this
gene is connected with the rest of the genes. Highly
connected genes have been referred to as “hub genes”
and are more likely to have important biological
functions.
In this article, we adopt the weighted co-expression
network developed by Dr. Steve Horvath and his collea-
gues. We provide a brief description of the weighted co-
expression network in the “Methods” section and refer
to [6] for more details. The weighted co-expression net-
work is built on the understanding that the coordinated
co-expressions of genes encode interacting proteins with
closely related biological functions and cellular processes
[7]. Extensive studies have shown that modules in the
weighted co-expression network usually have important
biological implications. In addition, genes with higher
connectivity are more likely to be involved in important
molecular processes. Incorporating connectivity in the
detection of differentially expressed genes can signifi-
cantly improve reproducibility [8-14].
There are other ways of defining gene networks.
Examples include the Boolean network, Bayesian net-
work, use of continuous models and others. Compared
with other networks, the weighted co-expression net-
work may have the following advantages. First, it is
computationally simple and can be easily constructed
using existing software. Second, it does not require any
additional biological experiments. And third, a large
n u m b e ro fp u b l i s h e ds t u d i e sh a v es h o w nt h a ti th a s
satisfactory empirical performance. On the other hand,
it may have certain drawbacks. The network is defined
based on the correlations among gene expressions,
which may not contain all of the information on the
coordination of genes. In addition, the network con-
struction is unsupervised and not tailored to any specific
traits or disease outcomes.
In this article, for cancer prognosis studies with gene
expression measurements, we construct the weighted
co-expression network and measure the relative impor-
tance of genes using their connectivity. We develop a
regularized gene selection method, which can effectively
take the connectivity into consideration. We note that
the proposed approach is relatively “independent” of the
network construction and thus applicable with other
networks. The proposed approach takes advantage of
recent developments in regularized gene selection and
network-based analysis but significantly advances from
them along the following directions. Unlike existing
methods that assume the interchangeability of genes,
the proposed approach can account for the network
structure and thus be more informative. This is partly
reflected in the improved prediction performance and
reproducibility. Unlike existing network analyses that
focus on the detection of genes or modules marginally
associated with phenotypes, the proposed approach can
account for the joint effects of multiple genes. Cancer
development and progression are caused by the joint
effects of multiple gene mutations or defects as opposed
to the disturbance of a single gene. Analysis that can
account for the joint effects of multiple genes is more
informative than analysis of marginal effects. An existing
approach that can account for the joint effects of multi-
ple genes is the eigengene-based approach. In eigengene
analysis, principal component analysis is conducted on
genes within the same modules. The first principal com-
ponents are used in downstream analysis. Principal com-
ponents use the linear combinations of all genes, which
make the analysis results difficult to interpret. In addi-
tion, even in a module significantly associated with can-
cer prognosis, noisy genes may still exist, especially
considering that the gene network is constructed in an
unsupervised manner and not tailored to any specific
cancer outcomes. The proposed approach conducts
gene selection, can effectively remove noisy genes, and
thus may have better interpretability.
Results
Data collection and processing
We collect six cancer prognosis studies with microarray
measurements. We refer to them as data D1-D6 and
provide brief descriptions below and in Table 1.
D1
Breast cancer is the second leading cause of death from
cancer among women in the United States. Despite
major progress in breast cancer treatment, the ability to
predict metastasis of the tumor remains limited. Huang
et al. [15] reported a study investigating metastastic
states and relapses in breast cancer patients. Affymetrix
genechips were used for the profiling of 71 samples.
Table 1 Description of datasets
Data Disease Platform Gene Sample
D1: Huang et al.
(2003) [15]
Breast
cancer
Affymetrix 12625 71
D2: Sotiriou et al.
(2003) [16]
Breast
cancer
cDNA 7650 98
D3: van’t Veer et al.
(2002) [17]
Breast
cancer
Oligonucleotide 24481 78
D4: Sorlie et al.
(2001) [18]
Breast
cancer
cDNA 8102 58
D5: Rosenwald et al.
(2003) [19]
MCL cDNA 8810 92
D6: Rosenwald et al.
(2002) [20]
DLBCL cDNA 7399 240
Platform: platforms used for profiling; Gene: number of gene expressions
measured; Sample: sample size.
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available.
D2
Sotiriou et al. [16] reported a study correlating gene
expression measurements generated using cDNA with
clinico-pathological characteristics and clinical outcomes
in an unselected group of 99 node-negative and node-
positive breast cancer patients. In the original analysis,
the Cox model was used to identify genes marginally
significantly associated with relapse-free survival. In this
study, we analyze the 98 patients with complete survival
information.
D3
Van’t Veer et al. [17] reported a breast cancer prognosis
study investigating the time to distant metastasis. 97
lymph node-negative breast cancer patients 55 years old
or younger participated in this study. Among them, 46
developed distant metastases within 5 years. Complete
information was available for 78 subjects. Expression
levels of 24,481 gene probes were measured.
D4
The study reported in [18] was originally designed to
classify breast carcinomas based on the variations in
gene expression patterns. A total of 85 cDNA microar-
ray experiments were conducted. This study showed
that the cancers could be classified into a basal epithe-
lial-like group, an ERBB2-overexpressing group, and a
normal breast-like group. In our study, we analyze a
subset of 58 patients who had survival information
available.
D5
A study using microarray expression analysis of man-
tle cell lymphoma (MCL) was reported in [19].
Among 101 untreated patients with no history of pre-
vious lymphoma, 92 were classified as having MCL
based on established morphologic and immunopheno-
typic criteria. Survival times of 64 patients were avail-
able, and the other 28 patients were censored. The
median survival time was 2.8 years. Lymphochip DNA
m i c r o a r r a y sw e r eu s e dt oq u a n t i f ym R N Ae x p r e s s i o n s
in the lymphoma samples from the 92 patients. Gene
expression data on 8,810 cDNA elements were
available.
D6
Rosenwald et al. [20] reported a diffuse large B-cell lym-
phoma (DLBCL) prognosis study. This study retrospec-
tively collected tumor biopsy specimens and clinical
data for 240 patients with untreated DLBCL. The med-
ian follow up was 2.8 years, with 138 observed deaths.
Lymphochip cDNA microarray was used to measure the
expressions of 7,399 genes.
Among the six studies, four used cDNA, one used oli-
gonucleotide arrays, and one used Affymetrix Genechips
for profiling. We process each dataset separately as
follows. We conduct microarray normalization using the
lowess approach for cDNA data and the robust multi-
array (RMA) approach for Affymetrix data. We impute
missing measurements using the K-nearest neighbors
approach. We select the 2,000 genes with the largest
variances for downstream analysis. Since we expect the
number of genes associated with cancer prognosis to be
far less than 2,000, we conduct this prescreening to
reduce computational cost. In addition, recent studies
have shown that prescreening may improve gene selec-
tion accuracy [21]. We then normalize gene expressions
to have zero median and unit variance.
Construction of weighted co-expression network
We construct the weighted co-expression network using
the approach described in the “Methods” section. For
dataset D1-D6, 10, 10, 13, 12, 13, and 10 modules are
constructed, respectively. More detailed results are avail-
able from the authors.
In studies conducted by Dr. Horvath and his collea-
gues, it has been observed that the marginal gene signif-
icance and intramodular connectivity are positively
correlated. For each gene, we fit a Cox model with the
expression of this gene as the only covariate. The mar-
ginal gene significance is defined as the estimated
regression coefficient from the marginal model. The
intramodular connectivity is defined in the “Methods”
section. Figure 1 shows that the marginal gene signifi-
cance and intramodular connectivity are positively cor-
related for five of the datasets and (weakly) negatively
correlated for one. Since the six datasets are “randomly”
selected, we conclude that the positive correlation
between marginal significance and intramodular connec-
tivity tends to, but not ne c e s s a r i l y ,h o l d s .W eh a v e
experimented with other gene significance measures (for
example, the log p-values from marginal models) and
obtained similar results.
Identification of prognosis markers
We apply the proposed approach and select the opti-
mal tunings using five-fold cross validation. Table 2
shows that, for each dataset, a small number of genes
are identified as prognosis markers. We provide more
detailed information, including gene names and their
estimated regression coefficients, in Additional File 1.
We search NCBI and published literature for the biolo-
gical implications of identified markers. We find that
many identified genes have been previously identified
as cancer markers. Details are provided in Additional
File 2. Of note, although datasets D1-D4 are all on
breast cancer, the corresponding studies had different
settings (patient selection criteria, demographics, etc).
Thus, we analyze them and interpret the identified
markers separately.
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An important goal of cancer genomic studies is to con-
struct predictive gene signatures. In addition, the evalua-
tion of prediction performance can also provide indirect
evaluation of the biological implications of genes. For
the six datasets, we consider the following cross valida-
tion-based evaluation: (a) For i = 1 ... n, remove subject
i from the data; (b) With the reduced data (with sample
size n - 1), carry out cross validation and regularized
estimation. Denote the estimated regression coefficient
as 
∧ − () i (we refer to the “Methods” section for the data
and model setup); (c) Compute the predictive risk score

∧ − () ′ i
i X
for the removed subject, where Xi is the gene
expression; (d) Repeat Steps (a)-(c) over all subjects; and
(e) Dichotomize the predictive scores at the median.
Create two risk groups. Compute the logrank statistic,
which measures the difference of survival between the
two groups [22]. Under the Null, the identified genes
have no predictive power, and the logrank statistic is c
2
distributed with degree of freedom 1. We show the pre-
dictive logrank statistics in Table 2. For all six datasets,
the prediction performance is satisfactory, with p-values
of the logrank statistics smaller than 0.05.
Beyond the prediction performance of all identified
genes combined, we are also interested in the
Figure 1 Marginal gene significance (estimated regression coefficient from marginal Cox model) versus intramodular connectivity. Red
curve: lowess estimate; Blue straight line: linear fit.
Table 2 Data analysis results: gene identification and
prediction
Gene identification Prediction logrank
Data TGDR Proposed Overlap TGDR Proposed
D1 33 32 25 14.6 20.4
D2 15 10 7 4.1 11.2
D3 15 19 10 7.7 22.3
D4 19 20 13 11.4 19.3
D5 14 23 8 7.3 23.0
D6 26 27 20 13.9 28.4
A logrank statistic greater than 3.84 is significant at the 0.05 level.
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following approach: (a) Remove one subject from the
data; (b) Conduct regularized estimation and gene selec-
tion using the reduced data with sample size n -1 ;( c )
Repeat Steps (a) and (b) over all subjects. For each gene,
count c, the number of times it is identified in the n
models. The ratio c/n provides a measure of reproduci-
bility and is referred to as the “occurrence index” in the
literature. Table 3 shows that the identified genes have
occurrence indexes close to 1, which suggests very satis-
factory reproducibility. In contrast, the genes not identi-
fied have much lower occurrence indexes.
Analysis with TGDR
To further gauge performance of the proposed
a p p r o a c h ,w ea n a l y z et h es a m ed a t au s i n gt h eT G D R
approach [23]. TGDR shares a similar thresholding reg-
ularization framework with the proposed approach. It
has been shown to have satisfactory performance in sev-
eral published studies. Unlike the proposed approach, it
assumes the interchangeability of genes.
With TGDR, we also select the optimal tunings using
five-fold cross validation. We show the estimation and
cross validation-based prediction results in Table 2.
TGDR also identifies a small number of genes. However,
t h eg e n es e t si d e n t i f i e db yT G D Ra n dt h ep r o p o s e d
approach can be significantly different. The TGDR pre-
diction logrank statistics are considerably smaller than
their counterparts under the proposed approach. We
also evaluate the reproducibility and present the results
in Table 3, showing that the occurrence indexes of
TGDR-identified genes are smaller than those of the
genes identified by the proposed approach.
Discussion and Conclusions
In cancer studies, the construction of prognosis signa-
tures from the analysis of high-throughput gene profil-
ing studies is of great importance. In this article, we
adopt the weighted co-expression network to describe
the intercorrelation among genes. We adopt the intra-
modular connectivity as the measure of node impor-
tance. We propose a thresholding regularization gene
selection approach, which directly accounts for the net-
work structure and encourages the selection of genes
with high intramodular connectivity. We analyze six
prognosis studies on breast cancer and lymphoma. We
find that the proposed approach can identify genes that
are significantly different from those using TGDR.
Genes identified using the proposed approach have
sound biological bases, better prediction performance,
and better reproducibility. As can be seen in the
“Methods” section, the proposed approach is also applic-
able when other networks are adopted as long as a node
importance measure like the intramodular connectivity
can be defined. Investigating performance of the pro-
posed approach under other networks and a systematic
comparison of different networks are of interest but
beyond the scope of this article.
For genes identified using the proposed approach, we
search NCBI and published literature and find that
many of them have sound biological bases and/or have
been previously identified as breast cancer/lymphoma
markers. This partly demonstrates the effectiveness of
the proposed approach. There are also new discoveries
that need to be further studied. We note that, although
the identified signatures seem reasonable, extensive
independent studies are needed to further validate those
signatures before they can be used in clinical practice.
We conduct prediction evaluation and find that the log-
rank statistics are highly significant for all six datasets
and larger than those under TGDR. One of the ultimate
g o a l so fg e n o m i cs t u d i e si st oi m p r o v ep r e d i c t i o np e r -
formance and reliability of disease signatures. The
improvement observed in this study, although may not
be dramatic, can still be valuable.
The proposed approach shares a similar thresholding
regularization framework with TGDR and other
thresholding methods. However, it differs significantly
from existing approaches by accounting for the net-
work structure. Conceptually, the selection is con-
ducted with respect to both gradient (which measures
gene importance in statistical models) and connectivity
(which measures gene importance in networks). The
proposed approach enjoys the advantages of TGDR
(for example, low computational cost) and has better
empirical performance. This study can be extended in
several directions. First, it may be interesting to inves-
tigate the performance of the proposed approach
under other networks and/or using other node impor-
tance measures. Second, gene signatures identified in
this study may be compared with those using other
methods and/or in other studies. Third, there are
many gene selection approaches that ignore the inter-
play among genes. It may be possible to follow a simi-
lar strategy and extend them to incorporate the
network structure. Lastly, it may be possible to
Table 3 Data analysis results: reproducibility evaluation
TGDR Proposed
Data Identified Not identified Identified Not identified
D1 0.858 [0.437, 1] 0 [0, 0.479] 0.951 [0.479, 1] 0 [0, 0.409]
D2 0.919 [0.459, 1] 0 [0, 0.602] 0.954 [0.561, 1] 0 [0, 0.520]
D3 0.970 [0.567, 1] 0 [0, 0.340] 0.979 [0.804, 1] 0 [0, 0.175]
D4 0.910 [0.431, 1] 0 [0, 0.586] 0.931 [0.603, 1] 0 [0, 0.328]
D5 0.919 [0.489, 1] 0 [0, 0.446] 1 [0.620, 1] 0 [0, 0.326]
D6 0.958 [0.633, 1] 0 [0, 0.442] 1 [0.663, 1] 0 [0, 0.313]
Median [range] of the occurrence index.
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tion using, for example, the pathway structure.
Methods
The proposed analysis consists of the following steps.
First, we construct statistical models linking gene
expressions with cancer survival outcomes. Second, we
construct the weighted co-expression network. The
rationale of the network construction and its pros and
cons have been discussed in detail elsewhere [6]. We
briefly discuss them for the integrity of this article. The
proposed approach is a thresholding regularized, itera-
tive approach. It uses gradient thresholding, can be
much more effective than the simple thresholding, and
significantly advances from other thresholding
approaches by accounting for the network structure.
Statistical modeling
We assume that the d gene expressions are associated
with cancer survival through the Cox proportional
hazards model [22], where the conditional hazard func-
tion l (t|X)=l0(t)e x p( b′ X). Here, l0(t)i st h e
unknown baseline hazard, and b is the length-d regres-
sion coefficient. We assume n iid copies of (Y, Δ, X):
(Yi, δi, Xi); i =1. . .n. Denote ri ={ k: Yk ≥ Yi}a st h ea t -
r i s ks e ta tt i m eYi. The log-partial likelihood function
is RX l o g X ni i ik kr i
   () = ′ − ′ () ( ) () ∑∑ ∈ exp .
Construction of weighted co-expression network
Construction of the weighted co-expression network
consists of the following steps.
1. For genes k and j (= 1 ... d), compute cor(k, j), the
Pearson correlation coefficient of their expressions.
Compute the similarity measure S(k, j)=| cor(k, j)|;
2. Compute the adjacency function ak, j = S
b (k, j),
where the adjacency parameter b is chosen using the
scale-free topology criterion;
3. For gene k, compute its connectivity Ca kk u u =∑ , ;
4. For gene k (= 1 ... d), compute the topological over-
lap based dissimilarity measure dk, j =1-ωk, j where
ωk, j =( lk, j + ak, j)/(min (Ck, Cj)+1-ak, j)a n d
la a kj ku ju u ,, , =∑ . Define the dissimilarity matrix D,
whose (k, j)th element is dk, j;
5. Identify network modules using matrix D and the
hierarchical clustering approach. Apply the dynamic tree
cut approach [24] to cut the clustering tree (dendro-
gram), and identify the resulting branches as modules;
6. For gene k, compute its intramodular connectivity
Ck
I , which is defined in a similar manner as in Step 3.
T h ed i f f e r e n c ei st h a tt h es u mi so v e rg e n e sw i t h i nt h e
same module.
In Steps 1 and 2, we define the adjacency measure
between genes using the power transformation of corre-
lation coefficients. We adopt the weighted network,
which can measure not only whether two genes are con-
nected but also the connection strength. The power
adjacency function has the attractive factorization prop-
erty. We find that, for the six datasets analyzed, b =6 ,
which has been suggested in several published studies,
can lead to results satisfying the scale-free topology cri-
terion. In Step 4, we use the topological overlap dissimi-
larity measure [25], which has been found to result in
biologically meaningful modules. Here, modules are
defined as sets of highly connected genes. The advan-
tage of the dynamic tree cut approach in Step 5 has
been discussed in [24]. We compute the intramodular
connectivity in Step 6, which can be more meaningful
than the whole-network connectivity.
Network based gene selection
The proposed approach uses thresholding regularization
to discriminate important genes from noisy ones. The
basic strategy is similar to that of simple thresholding
[26]. We first compute an importance measurement for
each gene. We then set a data-dependent threshold.
Genes with importance measures larger than the thresh-
old are identified, whereas genes with importance mea-
sures smaller than the threshold are screened out. Only
estimates for those identified genes are updated. The
“computing (significance), thresholding, and updating”
process iterates until a certain stopping criterion is
reached. In gene selection, we incorporate the network
structure and encourage the selection of genes with
higher intramodular connectivity. This strategy has been
motivated by the observation that intramodular connec-
tivity tends to be correlated with gene significance in
[8,11,14] as well as Figure 1.
Let Δν be the small positive increment. In the numeri-
cal implementation, we set Δν =1 0
-3.D e n o t e0≤ τ1,
τ2 ≤ 1 as the thresholds for gradient and connectivity,
respectively. The proposed approach consists of the fol-
lowing steps.
1. Initialize b =0 ;
2. With the current estimate of b, compute the length
d vector of gradient g = ∂ Rn/∂b.D e n o t egi as the ith
component of g;
3. Compute the length-d gradient thresholding vector f
1,
where its ith component is fI g m a x g ii l l
1
1 =≥ × () || || 
4. Compute the length-d connectivity thresholding
vector f
2,w h e r ei t sith component is
fI C f m a x C f ii
I
il l
I
l
21
2
1 =≥ × () 
5. Update the estimate   ii i ii gf f =+ × ×× Δ
12
6. Iterate Steps 2-5 K times, where K is determined via
cross-validation.
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algorithm starts with no gene identified (Step 1). In Step
2, we compute the gradients, which measure the
increase in likelihood if the corresponding estimates are
updated. Thus, the gradients can measure the relative
importance of genes in maximizing the likelihood func-
tion. Particularly, it is expected that more important
genes tend to have larger gradients. As one reviewer
pointed out, it is possible to use a more formal impor-
tance measure (for example, for a hypothesis testing).
However, we note that, such a measure may not be
directly related to maximization of likelihood, can be
computationally expensive, and hence is not pursued. In
Steps 3 and 4, thresholding regularization is used to
select important genes. More specifically, in Step 3, we
compare the gradient of a gene with those of the others.
This step of thresholding can remove unimportant
genes with small gradients. In Step 4, for genes with
large gradients, we add the second level of thresholding
and select those with large connectivity. By combining
the two thresholding vectors in Step 5, we select genes
with not only large gradients but also high connectivity.
Only estimates of those selected genes are updated.
The proposed approach involves three tuning para-
meters. Their effects on the regularized estimates are as
follows. When K is fixed, the values of the thresholds
affect the level of sparsity. Particularly, when the thresh-
olds decrease, the number of genes (identified as impor-
tant) increases. When the thresholds are fixed and K
increases, the number of genes (identified as important)
increases.
We select the values of K and thresholds using V-fold
cross validation, which can provide partial protection
against overfitting. In our data analysis, we find that the
cross validation-selected tunings can effectively balance
between the goodness-of-fit and model sparsity. Our
limited experiences suggest that the proposed approach
has satisfactory convergence properties and stability.
Additional file 1: Data analysis results. This Excel file contains
information on the genes identified using the proposed approach and
the estimated regression coefficients.
Additional file 2: Detailed information on the identified genes.T h i s
.pdf file contains detailed information on the biological implications of
the identified prognosis markers.
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